Diasome Pharmaceuticals is a clinical stage diabetes therapeutics company that designs and develops insulin-based therapies.

Biotechnology

Health Care

Life Sciences

Therapeutics

Diasome Pharmaceuticals

Diasome Pharmaceuticals' headquarters in Cleveland, OH, United States

Robert Geho

Douglas Muchmore

Christine Smith

Marc Penn

W. Blair Geho

Frank McCaney

Martin Lafontaine

Bruce Bode

Eric Edidin

Jeremy Pettus

Peter A. Tollman

Thomas McDonald

The Advisory Board at Diasome Pharmaceuticals provides strategic guidance and expertise to support the development of innovative insulin-based therapies. Comprising industry leaders and specialists, the team advises on clinical trial design, regulatory strategies, and market positioning to enhance the company's impact in the diabetes therapeutics field. Their diverse perspectives help ensure that Diasome's initiatives align with scientific advancements and patient needs.

Advisory Board

The Leadership Team at Diasome Pharmaceuticals is responsible for guiding the company’s strategic direction and overall management, ensuring the successful development and commercialization of insulin-based therapies for diabetes. This team, composed of key executives including the CEO, CTO, CMO, and other co-founders, collaborates on clinical strategies, operational excellence, and innovative technological advancements, while also engaging with stakeholders to drive the company's mission forward.

Leadership Team

Diasome Pharmaceuticals

Org chart

Board & advisors

Teams

Advisory Board

Leadership Team

Offices

Diasome Pharmaceuticals

Org chart

Board & advisors

Teams

Advisory Board

Leadership Team

Offices

Related companies